Fintel reports that on October 1, 2024, Stephens & Co. initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a ...

Thermo Fisher (TMO) stock slips as plant producing RSV treatment. Beyfortus developed by AstraZeneca (AZN), Sanofi (SNY) ...

Thermo Fisher's business strategy involves expansion through strategic acquisition of technologies and businesses that boost ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements ...

It was a tough weekend for the Welsh sides in the United Rugby Championship, with all four falling to defeats. Cardiff came ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $612.94 which represents a decrease of $-5.63 or -0.91% from the prior close of $618.57. The stock opened at $620 and touched ...

Bristol deliver a first defeat of the season on an out-of-sorts Bath in a dominant West Country derby display.

Thermo Fisher Scientific TMO announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory ...